Dogwood Therapeutics (NASDAQ:DWTX) Trading Up 15.6% – Here’s What Happened

Dogwood Therapeutics, Inc. (NASDAQ:DWTX) shot up 15.6% during mid-day trading on Thursday . The company traded as high as $7.16 and last traded at $6.83. 218,034 shares traded hands during mid-day trading, a decline of 89% from the average session volume of 2,020,999 shares. The stock had previously closed at $5.91.

Dogwood Therapeutics Stock Up 15.6 %

The company has a market cap of $9.10 million, a P/E ratio of -1.04 and a beta of 2.07. The stock’s fifty day simple moving average is $7.20.

Institutional Trading of Dogwood Therapeutics

An institutional investor recently bought a new position in Dogwood Therapeutics stock. Geode Capital Management LLC purchased a new stake in Dogwood Therapeutics, Inc. (NASDAQ:DWTX) during the fourth quarter, according to its most recent filing with the SEC. The fund purchased 10,933 shares of the company’s stock, valued at approximately $27,000. Geode Capital Management LLC owned about 0.82% of Dogwood Therapeutics as of its most recent filing with the SEC. 9.05% of the stock is owned by institutional investors and hedge funds.

About Dogwood Therapeutics

Dogwood Therapeutics, Inc is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia.